Work

ECOG-ACRIN LUNG-MAP S1900E substudy: A phase II study of sotorasib in participants (Pts) with previously treated stage IV or recurrent KRAS G12C mutant non-squamous (Non-sq) non-small cell lung cancer (NSCLC).

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.tps9143

Authors: Sukhmani Kaur Padda, Mary Weber Redman, David E Gerber, Tom Stinchcombe, Saiama Naheed Waqar, Ticiana Leal, Katherine Minichiello, Karen L. Reckamp, Roy S. Herbst, Hossein Borghaei, Julie R. Brahmer, Jhanelle Elaine Gray, Karen Kelly, Suresh S. Ramalingam, Joel W. Neal

Institutions: Cedars-Sinai Medical Center, Fred Hutch Cancer Center, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Duke University, Duke Cancer Institute, Washington University in St. Louis, Winship Cancer Institute, Yale Cancer Center, Yale University, Smilow Cancer Hospital, Fox Chase Cancer Center, Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, Moffitt Cancer Center, UC Davis Comprehensive Cancer Center, Emory University, Stanford Medicine

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4379280941

Cites:

Cited by: 3

Related to: 10